Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice
Anisha Apte, Pujarini Dutta Dey, Srisaianirudh Reddy Julakanti, Monica Midura-Kiela, Stacy M. Skopp, Jimena Canchis, Tobias Fauser, James Bardill, Sudipta Seal, David M. Jackson, Fayez K. Ghishan, Pawel R. Kiela, Carlos Zgheib, Kenneth W. Liechty · 2024
Read Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice by Anisha Apte, Pujarini Dutta Dey, Srisaianirudh Reddy Julakanti, Monica Midura-Kiela, Stacy M. Skopp, Jimena Canchis, Tobias Fauser, James Bardill, Sudipta Seal, David M. Jackson, Fayez K. Ghishan, Pawel R. Kiela, Carlos Zgheib, Kenneth W. Liechty (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11679827.txt.
Description
Anisha Apte and a large team deliver a gene-silencing therapy by mouth to calm gut inflammation in mice, in a 2024 study. The therapy pairs a small RNA, miR146a, with cerium oxide nanoparticles that soak up harmful oxygen radicals. Together they attack the inflammation and oxidative stress that drive inflammatory bowel disease. The team first checked that the particles survive simulated gut fluid and reach the gut lining after feeding.
They then treated mice with established, long-running colitis driven by T cells. The oral therapy improved the disease, as the title reports. Swallowing a nanoparticle medicine is far easier for patients than injections, and a treatment that fights on two fronts at once could help where single-target drugs stall.
Catalog record
| CREATOR | Anisha Apte, Pujarini Dutta Dey, Srisaianirudh Reddy Julakanti, Monica Midura-Kiela, Stacy M. Skopp, Jimena Canchis, Tobias Fauser, James Bardill, Sudipta Seal, David M. Jackson, Fayez K. Ghishan, Pawel R. Kiela, Carlos Zgheib, Kenneth W. Liechty |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |